RECRUITING

NeuroGlove Anxiety and Depression Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a prospective, homebased, interventional clinical study containing 10 subjects who will be enrolled. Approximately 10 (10) subjects with active anxiety and depression symptoms will receive treatment using the NeuroGlove.

Official Title

Impact of Peripheral Sensory Stimulation of the Hand and Synchronized Deep Breathing in the Treatment of Anxiety and Depression: Assessing Safety and Effectiveness

Quick Facts

Study Start:2023-09-27
Study Completion:2024-11-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06065787

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 85 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Able to and willing to provide informed consent. Legally authorized representatives (LARs) will not be allowed to consent on behalf of the subject.
  2. * Men and women ≥18 and \<85 years of age.
  3. * Carry an active diagnosis of anxiety and/or depression.
  4. * Suffer from anxiety and/or depression symptoms that impact subject's daily activities and quality of life.
  1. * Physical limitations of the upper extremity (e.g., fracture, joint deformity, severe spasticity/contracture, wounds, skin breakdown, lymphedema, etc.)
  2. * The subject lacks the ability to comprehend or following instructions, or for any reason, in the opinion of the investigator, would be unlikely or unable to comply with study protocol requirements.
  3. * Currently participating in another interventional clinical trial. (Observational clinical trial participation is allowed for study enrollment.)

Contacts and Locations

Study Contact

Thomas Harold
CONTACT
6122550405
info@neuroglove.net

Principal Investigator

Eric Nussbaum, MD
PRINCIPAL_INVESTIGATOR
NeuroGlove LLC

Study Locations (Sites)

NeuroGlove
Minneapolis, Minnesota, 55416
United States

Collaborators and Investigators

Sponsor: NeuroGlove LLC

  • Eric Nussbaum, MD, PRINCIPAL_INVESTIGATOR, NeuroGlove LLC

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-09-27
Study Completion Date2024-11-01

Study Record Updates

Study Start Date2023-09-27
Study Completion Date2024-11-01

Terms related to this study

Keywords Provided by Researchers

  • Anxiety
  • Depression

Additional Relevant MeSH Terms

  • Anxiety
  • Depression
  • Anxiety Depression
  • Depression, Anxiety